Disclaimer

NITROGLYCERIN-INJECTION, Nitro-Bid, Tridil (cont.)

DRUG INTERACTIONS: This drug should not be used with the following medications because very serious (possibly fatal) interactions may occur: drugs to treat impotence (e.g., sildenafil, vardenafil, tadalafil). If you are currently using any of these medications, tell your doctor or pharmacist before starting nitroglycerin. Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: heparin, drugs for high blood pressure (e.g., ACE inhibitors such as fosinopril or lisinopril, alpha blockers such as prazosin or doxazosin, beta-blockers such as propranolol), antipsychotics for mental conditions (e.g., chlorpromazine, haloperidol), other nitrate drugs such as isosorbide, "dopamine-like" drugs such as bromocriptine or cabergoline. Do not start or stop any medicine without doctor or pharmacist approval.

OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include a persistent, throbbing headache; dizziness; confusion; weakness; sweating; changes in heart rate; changes in vision; flushing; nausea; and vomiting.

NOTES: Frequent medical tests (e.g., blood pressure, heart monitoring) will be done to monitor for effectiveness and side effects.

MISSED DOSE: Not applicable as this drug is given by continuous infusion.

STORAGE: Store at room temperature away from light and moisture. Do not freeze.


Last Editorial Review: 3/2/2005



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright